Shenzhen Landu Biomaterials Co., Ltd. implants orthopedic medical materials and starts construction of high-risk medical device GMP workshop
Shenzhen Landu Biomaterials Co., Ltd. was founded in early 2010 by several PhDs from Tsinghua University and the Shenzhen Tsinghua University Research Institute. It brought together many like-minded people at home and abroad and is committed to the research, development and industrialization of biomedical materials and high-end medical devices. In the past ten years, the field of biomedical materials has maintained a global growth rate of 20%, and the market size has reached nearly 200 billion US dollars: the domestic market is nearly 100 billion yuan, and more than 80% of high-tech products rely on imports.
The company has built a first-class R&D team composed of cross-disciplinary professionals in biomaterials, chemistry, life sciences, clinical medicine, polymers, precision manufacturing and other disciplines. It focuses on the four major fields of trauma medical materials, orthopedic medical materials, oral medical materials, and drug carrier materials. It has developed multiple series of products with independent intellectual property rights, continuously accumulated core competitiveness, and provided strong power and support for the development and growth of the company. Qikang Medical, its holding subsidiary, has more than 1,000 square meters of clean workshops and laboratories with 10,000-level and 100,000-level cleanliness, and has achieved rapid development of two series of products, negative pressure drainage and wound care material sets and artificial skin.
The company has received comprehensive technical support and strategic cooperation from Shenzhen Tsinghua University Research Institute, and has jointly built the Lando Biomaterials R&D Center with the Key Laboratory of Biomedical Materials and Implantable Devices of Shenzhen Tsinghua University Research Institute. The company has also established good cooperative relationships with Tsinghua University, South China University of Technology, PLA General Hospital, Navy General Hospital, Peking University School of Stomatology, Pearl River Hospital of Southern Medical University, First Affiliated Hospital of Sun Yat-sen University, Jingzhou Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Shenzhen Second People's Hospital and other units.
Product Introduction
Product name: Negative pressure drainage and wound care material set
Scope of application: This product is used for continuous negative pressure closed drainage operations. It is suitable for various acute wounds, skin and soft tissue wounds and/or defects, application in the recipient area after skin grafting, ulcers, bedsores caused by various reasons, and wounds that require drainage after surgery. Negative pressure drainage wound treatment technology is a new technology developed in recent years for treating wounds. It uses a biological semi-permeable membrane to seal the open wound. At the same time, a negative pressure suction device is connected to a special wound dressing to intermittently or continuously generate pressure below atmospheric pressure on the wound surface to promote wound healing. This technology has become widely popular in European and American countries and is hailed as a revolutionary technology for the current treatment of trauma and a new milestone in the field of trauma care.
The technical parameters of Qiyi's negative pressure drainage and wound care material set have reached the international advanced level, and it has applied for a number of national invention patents and utility model patents, realizing serial development of products.
Product name: Double layer artificial skin
Fields of immediate use: Deep and third-degree burns; traumatic skin defects; skin cosmetology after resection of ulcers, congenital pigmentation or fetal marks; protection of skin donor areas; immediate coverage for battlefield rescue.
Artificial skin is a skin substitute artificially developed in vitro using the principles and methods of engineering and biology. It is used to repair and replace defective skin tissue, protect wounds from infection, and promote the growth of connective tissue. In recent years, due to the development and application of molecular biology and tissue engineering technology, scientists from various countries have been committed to the development of artificial skin. Currently, only a few countries such as Europe and the United States have mastered this technology.
Based on materials science, engineering and cell biology technology, Lando's R&D team successfully developed a double-layer artificial skin and achieved mass production. The artificial skin is similar in composition and structure to the human body's natural skin. It has good biosafety, biocompatibility, and the ability to prevent post-injury dehydration and infection, and can significantly speed up wound repair. The core technology has reached the international advanced level and has applied for 6 national invention patents.